Literature DB >> 21897047

Consumption of soy protein isolate reduces hepatic SREBP-1c and lipogenic gene expression in wild-type mice, but not in FXR-deficient mice.

Tsutomu Hashidume1, Takashi Sasaki, Jun Inoue, Ryuichiro Sato.   

Abstract

We examined to determine whether hepatic gene expression is affected in mice in which blood lipid levels remain unchanged fed soy protein isolate (SPI) for a short time. We also examined SPI-mediated effects in farnesoid X receptor (FXR)-deficient mice. Compared with casein, SPI affected the expression of various hepatic genes related to lipid metabolism in the wild-type mice. No effects of SPI were observed in the FXR-deficient mice, suggesting the importance of FXR. Hepatic peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) gene expression was reduced by SPI, and this might be associated with a decrease in FXR expression. Decreased FXR led to decreased expression of its target, the bile-salt export pump necessary for bile acid secretion and dietary lipid absorption. The earliest response to SPI was a decrease in hepatic sterol regulatory element-binding protein (SREBP)-1c mRNA, on day 3. SPI activated hepatic adenosine monophosphate-activated protein kinase (AMPK), which can lead to a reduction in SREBP-1c mRNA. These data indicate the importance of SREBP-1c and PGC-1α/FXR in SPI-mediated alterations in hepatic gene expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21897047     DOI: 10.1271/bbb.110224

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  Low-ω3 Fatty Acid and Soy Protein Attenuate Alcohol-Induced Fatty Liver and Injury by Regulating the Opposing Lipid Oxidation and Lipogenic Signaling Pathways.

Authors:  Karina Reyes-Gordillo; Ruchi Shah; Ravi Varatharajalu; Mamatha Garige; Leslie C Leckey; M Raj Lakshman
Journal:  Oxid Med Cell Longev       Date:  2016-12-18       Impact factor: 6.543

2.  Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH.

Authors:  Mikael Bjursell; Marianne Wedin; Therése Admyre; Majlis Hermansson; Gerhard Böttcher; Melker Göransson; Daniel Lindén; Krister Bamberg; Jan Oscarsson; Mohammad Bohlooly-Y
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

Review 3.  Gut Microbiota and Lifestyle Interventions in NAFLD.

Authors:  David Houghton; Christopher J Stewart; Christopher P Day; Michael Trenell
Journal:  Int J Mol Sci       Date:  2016-03-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.